Richard Aarnio

Obesity risk is associated with altered cerebral glucose metabolism and decreased μ-opioid and CB1 receptor availability

Tatu Kantonen, Laura Pekkarinen, Tomi Karjalainen et al. · International Journal of Obesity · 2021 · 34 citations · Full text

Medicine, Endocrinology, Neuroscience +17

ASIC-E4: Interplay of Beta-Amyloid, Synaptic Density and Neuroinflammation in Cognitively Normal Volunteers With Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease – Study Protocol and Baseline Characteristics

Anniina Snellman, Laura L. Ekblad, Mikko Koivumäki et al. · Frontiers in Neurology · 2022 · 18 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Novel plasma protein binding analysis method for a PET tracer and its radiometabolites: A case study with [11C]SMW139 to explain the high uptake of radiometabolites in mouse brain

Richard Aarnio, Obada M. Alzghool, Saara Wahlroos et al. · Journal of Pharmaceutical and Biomedical Analysis · 2022 · 15 citations · Full text

Medicine, Nuclear Medicine, Pharmacokinetics +16

Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation

Susanne Vainio, Alex M. Dickens, Markus Matilainen et al. · EJNMMI Research · 2022 · 13 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

SV2A PET shows hippocampal synaptic loss in cognitively unimpaired <i>APOE</i> ε4/ε4 homozygotes

Anniina Snellman, Jouni Tuisku, Mikko Koivumäki et al. · Alzheimer s & Dementia · 2024 · 12 citations · Full text

Life Sciences, Neurology, Neuroscience +17